Onychomadesis and onycholysis associated with capecitabine.
Chen
G Y
GY
Chen
Y H
YH
Hsu
M M
MM
Tsao
C J
CJ
Chen
W C
WC
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D005500:Follow-Up Studies; D006801:Humans; D009264:Nails, Malformed / Q000139:chemically induced*; D011355:Prodrugs / Q000009:adverse effects*
D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil